Medicina
Facultad
JOSÉ ANTONIO
RAMOS ATANCE
Investigador hasta 2020
Publicaciones en las que colabora con JOSÉ ANTONIO RAMOS ATANCE (167)
2023
-
El gen del receptor cannabinoide tipo 2 se asocia con la comorbilidad entre esquizofrenia y dependencia de cannabis y el gen de la enzima amidohidrolasa de ácidos grasos se asocia con la dependencia de cannabis en población española
Adicciones: Revista de socidrogalcohol, Vol. 35, Núm. 1, pp. 33-45
2018
-
Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system
Biochemical Pharmacology, Vol. 157, pp. 67-84
-
Ingroducción a la farmacología del sistema nervioso central: neurotransmisores, receptores y otros elementos sinápticos
Velázquez. Farmacología básica y clínica (Editorial Médica Panamericana), pp. 179-208
2017
-
Altered striatal endocannabinoid signaling in a transgenic mouse model of spinocerebellar ataxia type-3
PLoS ONE, Vol. 12, Núm. 4
-
Modeling Neurodegenerative Disorders for Developing Cannabinoid-Based Neuroprotective Therapies
Methods in Enzymology (Academic Press Inc.), pp. 175-198
2016
2015
-
Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders
Journal of Neuroimmune Pharmacology, Vol. 10, Núm. 2, pp. 233-244
2012
-
Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects
Neuropharmacology, Vol. 62, Núm. 7, pp. 2299-2308
2011
-
Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease
Journal of Neuroscience Research, Vol. 89, Núm. 9, pp. 1509-1518
-
New serotonin 5-HT 1A receptor agonists with neuroprotective effect against ischemic cell damage
Journal of Medicinal Chemistry, Vol. 54, Núm. 23, pp. 7986-7999
-
Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults
PLoS ONE, Vol. 6, Núm. 8
-
Prospects for cannabinoid therapies in basal ganglia disorders
British Journal of Pharmacology, Vol. 163, Núm. 7, pp. 1365-1378
-
Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ 9-THCV in animal models of Parkinson's disease
British Journal of Pharmacology, Vol. 163, Núm. 7, pp. 1495-1506
2010
-
Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders
CNS Neuroscience and Therapeutics, Vol. 16, Núm. 3
-
Gender-specific COMT Val158Met polymorphism association in Spanish schizophrenic patients
American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 153, Núm. 1, pp. 79-85
2009
-
Actualización sobre el potencial terapéutico de los cannabinoides
Sociedad Española de Investigación en Cannabinoides (SEIC)
-
Effects of a short-term exposure to alcohol in rats on FAAH enzyme and CB1 receptor in different brain areas
Drug and Alcohol Dependence, Vol. 99, Núm. 1-3, pp. 354-358
-
Lack of association between polymorphisms in cannabinoid receptor gene (CNR1) and fatty acid amide hydroxylase gene (FAAH) and eating disorders in a preliminary study
Psychiatric Genetics, Vol. 19, Núm. 6, pp. 336
-
Relación del sistema cannabinoide con la fisiopatología y el tratamiento de la esquizofrenia
Actualización sobre el potencial terapéutico de los cannabinoides (Sociedad Española de Investigación en Cannabinoides (SEIC)), pp. 239-256
2008
-
CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats
Neuropharmacology, Vol. 54, Núm. 6, pp. 976-988